Brief: Epigenomics 9-month EBITDA Down At EUR -9.7 Mln

Epigenomics AG

19/11/2019 07:03

Nov 19 (Reuters) - EPIGENOMICS AG  ECXn.DE :
    * 9MTH EBITDA (BEFORE SHARE-BASED PAYMENT EXPENSES)
DECREASED FROM
EUR -8.0 MILLION IN COMPARABLE PERIOD OF 2018 TO EUR -9.7
MILLION
    * EXPECTS FULL-YEAR 2019 REVENUE IN A RANGE OF EUR 1.0
MILLION TO
EUR 1.5 MILLION
    * 9-MONTH NET LOSS FOR PERIOD WAS EUR -10.0 MILLION (9M
2018: EUR
-8.7 MILLION)
    * 9-MONTH TOTAL REVENUE FOR PERIOD DECREASED YEAR-ON-YEAR TO
EUR
847 THOUSAND (9M 2018: EUR 1,315 THOUSAND)
    * FOR EBITDA BEFORE SHARE-BASED PAYMENT EXPENSES,
EPIGENOMICS
FORECASTS A RANGE OF EUR -12.5 MILLION TO EUR -14.0 MILLION FOR
FULL YEAR 2019

Source text for Eikon:  ID:nEQ5B7bSDa 
Further company coverage:  ECXn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))